10x Genomics, Inc. Class A Common Stock
$76.60
-$0.37 (-0.48%)
$75.21Day Range$78.08
Key Statistics
Market Cap
$9.98B
Shares Outstanding
130.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 12, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$77.64
Day High
$78.08
Day Low
$75.21
Volume
2.89M
VWAP
$76.45
Prev Close
$76.97
Transactions
--
Acc. Volume
--
About 10x Genomics, Inc. Class A Common Stock
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
LABORATORY ANALYTICAL INSTRUMENTSSIC 38261,178 employees6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588(925) 401-7300IPO Sep 12, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001770787
- Composite FIGI
- BBG007WX14X0
- Share Class FIGI
- BBG007WX14Y9
- Ticker Root
- TXG
- SIC Code
- 3826
About 10x Genomics, Inc. Class A Common Stock (TXG) Stock
10x Genomics, Inc. Class A Common Stock (TXG) closed the 2026-09-18 session at $76.60, down 0.48% versus the previous close (-0.37). The stock opened at $77.64 and traded between $75.21 and $78.08 during that session. Session trading volume was 2.9M shares. The volume-weighted average price (VWAP) is $76.45.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
10x Genomics, Inc. Class A Common Stock has a market capitalization of $9.98 billion. The company operates in the LABORATORY ANALYTICAL INSTRUMENTS industry classification. TXG is listed on the XNAS exchange. The company employs approximately 1,178 people. 10x Genomics, Inc. Class A Common Stock is headquartered in PLEASANTON, CA. The recorded listing date is 2019-09-12.
On this page you can find market TXG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the LABORATORY ANALYTICAL INSTRUMENTS sector.